MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Intersect ENT Company Profile (NASDAQ:XENT)

Consensus Ratings for Intersect ENT (NASDAQ:XENT) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $34.00 (34.33% upside)

Analysts' Ratings History for Intersect ENT (NASDAQ:XENT)
Show:
DateFirmActionRatingPrice TargetActions
8/17/2015Canaccord GenuityReiterated RatingBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Cantor FitzgeraldReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Canaccord GenuityReiterated RatingBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015Cantor FitzgeraldInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Leerink SwannBoost Price TargetOutperform$32.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Canaccord GenuityBoost Price TargetBuy$27.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015JPMorgan Chase & Co.Boost Price TargetOverweight$28.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Canaccord GenuityReiterated RatingBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Leerink SwannBoost Price TargetOutperform$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2015Piper JaffrayBoost Price TargetOverweight$25.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015CRT CapitalInitiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Canaccord GenuityInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015JPMorgan Chase & Co.Boost Price TargetOverweight$22.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2014William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014WedbushInitiated CoverageOutperform$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014JPMorgan Chase & Co.Initiated CoverageOverweight$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Leerink SwannInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Piper JaffrayInitiated CoverageOverweight$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha